Two additional cases of progressive multifocal leukoencephalopathy (PML) have been reported with the lymphoma drug brentuximab vedotin (Adcetris), acc...
A novel agent has shown activity in relapsed or refractory Hodgkin lymphoma (HL), but it can cause severe adverse events and even death at a high dosa...
First results from a phase 3 trial of the vaccine candidate RTS,S/AS01 indicate it provides young African children with protection against clinical an...
Using induced pluripotent stem (iPS) cells, researchers have corrected the genetic alteration that causes sickle cell disease (SCD). The corrected st...
The lifetime ban on blood donation from men who have sex with men (MSM) has been lifted in England, Wales, and Scotland. Beginning in November, MSM ...
These results were presented at the European Society of Cardiology Congress in Paris on August 28 and published simultaneously online in The New Engla...
The US Food and Drug Administration (FDA) has granted accelerated approval for brentuximab vedotin (Adcetris) to treat patients with Hodgkin lymphoma ...
